Kamel Khalili, Excision BioTherapeutics
FDA clears first-of-its-kind trial to see if CRISPR gene editing can cure HIV
The FDA has cleared a company trying to use CRISPR gene-editing to cure HIV to begin clinical trials.
The study, run by the startup Excision …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
